Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cerebrovascular Disorders

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    February 2019
  1. HYLEK EM
    Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
    Circulation. 2019;139:772-774.
    PubMed     Text format    


    January 2019
  2. PICCINI JP, Xu H, Cox M, Matsouaka RA, et al
    Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035909.
    PubMed     Text format     Abstract available


  3. BENJAMIN EJ, Muntner P, Alonso A, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
    Circulation. 2019 Jan 31:CIR0000000000000659. doi: 10.1161/CIR.0000000000000659.
    PubMed     Text format    


  4. SHARMA M, Hart RG, Connolly SJ, Bosch J, et al
    Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.035864.
    PubMed     Text format     Abstract available


  5. OKAZAKI S, Morimoto T, Kamatani Y, Kamimura T, et al
    Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
    Circulation. 2019;139:295-298.
    PubMed     Text format    


  6. SCHWAMM LH
    Digital Health Strategies to Improve Care and Continuity Within Stroke Systems of Care in the United States.
    Circulation. 2019;139:149-151.
    PubMed     Text format    


    December 2018

  7. Correction to: Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of
    Circulation. 2018;138:e783.
    PubMed     Text format    


  8. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    PubMed     Text format     Abstract available


    November 2018
  9. SAVITZ SI, Yavagal D, Rappard G, Likosky W, et al
    A Phase 2 Randomized, Sham Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow Derived ALD-401 Cells in Patients with Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.117.030659.
    PubMed     Text format     Abstract available


  10. BASSAND JP, Virdone S, Goldhaber SZ, Camm AJ, et al
    Early Risks of Death, Stroke/Systemic Embolism and Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation: Results from the GARFIELD-AF Registry.
    Circulation. 2018 Nov 28. doi: 10.1161/CIRCULATIONAHA.118.035012.
    PubMed     Text format     Abstract available


  11. BERG DD, Ruff CT, Jarolim P, Giugliano RP, et al
    Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038312.
    PubMed     Text format     Abstract available


    October 2018
  12. MAHESHWARI A, Norby FL, Roetker NS, Soliman EZ, et al
    Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: The Atherosclerosis Risk in Communities (ARIC) Study and Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2018 Oct 2. doi: 10.1161/CIRCULATIONAHA.118.035411.
    PubMed     Text format     Abstract available


    September 2018
  13. GEORGAKIS MK, Gill D, Rannikmae K, Traylor M, et al
    Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1.
    Circulation. 2018 Sep 26. doi: 10.1161/CIRCULATIONAHA.118.035905.
    PubMed     Text format     Abstract available


  14. MENON BK, Xu H, Cox M, Saver JL, et al
    Components and Trends in Door to Treatment Times for Endovascular Therapy in GWTG-Stroke Hospitals.
    Circulation. 2018 Sep 21. doi: 10.1161/CIRCULATIONAHA.118.036701.
    PubMed     Text format     Abstract available


  15. DAWSON J
    Pioglitazone Use After Stroke.
    Circulation. 2018;138:1221-1223.
    PubMed     Text format    


  16. KOH KK
    Letter by Koh Regarding Article, "PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)".
    Circulation. 2018;138:1283-1284.
    PubMed     Text format    


  17. COLOMBO PC, Mehra MR, Goldstein DJ, Estep JD, et al
    Comprehensive Analysis of Stroke in the LongTerm Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump.
    Circulation. 2018 Sep 17. doi: 10.1161/CIRCULATIONAHA.118.037231.
    PubMed     Text format     Abstract available


    August 2018

  18. Correction to: Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2018;138:e123.
    PubMed     Text format    


    July 2018
  19. OVERVAD TF, Larsen TB, Nielsen PB
    Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:443-444.
    PubMed     Text format    


  20. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VASc-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:441-442.
    PubMed     Text format    


  21. AL SULTAN AS, Hill MD
    Acute Ischemic Stroke Biology Demands Fast Treatment.
    Circulation. 2018;138:241-243.
    PubMed     Text format    


    June 2018
  22. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    PubMed     Text format     Abstract available


  23. WEINBERG I, Beckman JA, Shu Y, Jaff MR, et al
    Response by Weinberg et al to Letter Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjec
    Circulation. 2018;137:2676-2677.
    PubMed     Text format    


  24. SU Q, Ye Z, Li L
    Letter by Su et al Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Stan
    Circulation. 2018;137:2674-2675.
    PubMed     Text format    


  25. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    PubMed     Text format    


  26. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    PubMed     Text format    


  27. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    PubMed     Text format    


  28. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    PubMed     Text format    


  29. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    PubMed     Text format    


    May 2018
  30. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed     Text format    


    March 2018
  31. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    PubMed     Text format     Abstract available


  32. MULDER MJHL, Jansen IGH, Goldhoorn RB, Venema E, et al
    Time to Endovascular Treatment and Outcome in Acute Ischemic Stroke: MR CLEAN Registry Results.
    Circulation. 2018 Mar 26. pii: CIRCULATIONAHA.117.032600.
    PubMed     Text format     Abstract available



  33. Correction to: Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
    Circulation. 2018;137:e493.
    PubMed     Text format    


    February 2018
  34. HICKS KA, Mahaffey KW, Mehran R, Nissen SE, et al
    2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
    Circulation. 2018;137:961-972.
    PubMed     Text format     Abstract available


  35. NIELSEN PB, Skjoth F, Overvad TF, Larsen TB, et al
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation. 2018;137:832-840.
    PubMed     Text format     Abstract available


    January 2018
  36. BENJAMIN EJ, Virani SS, Callaway CW, Chang AR, et al
    Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
    Circulation. 2018 Jan 31. pii: CIR.0000000000000558.
    PubMed     Text format    


  37. ALBERTS MJ, Ollenschleger MD, Nouh A
    DAWN of a New Era for Stroke Treatment: Implications of the DAWN Study for Acute Stroke Care and Stroke Systems of Care.
    Circulation. 2018 Jan 18. pii: CIRCULATIONAHA.118.033579.
    PubMed     Text format     Abstract available


  38. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Circulation. 2018;137:103-105.
    PubMed     Text format    


    December 2017
  39. NTAIOS G, Hart RG
    Embolic Stroke.
    Circulation. 2017;136:2403-2405.
    PubMed     Text format    


  40. CAMPBELL BCV, Donnan GA, Davis SM
    Optimizing Systems of Care for Endovascular Thrombectomy in Ischemic Stroke: Drip and Ship Versus Mothership.
    Circulation. 2017;136:2322-2324.
    PubMed     Text format    


    November 2017
  41. MEFFORD MT, Rosenson RS, Cushman M, Farkouh ME, et al
    PCSK9 Variants, LDL-Cholesterol, and Neurocognitive Impairment: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2017 Nov 16. pii: CIRCULATIONAHA.117.029785.
    PubMed     Text format     Abstract available


  42. KHERA R, Hong JC, Saxena A, Arrieta A, et al
    Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.030128.
    PubMed     Text format     Abstract available


    October 2017
  43. YAGHI S, Furie KL, Viscoli CM, Kamel H, et al
    Pioglitazone Prevents Stroke in Patients with a Recent TIA or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial.
    Circulation. 2017 Oct 30. pii: CIRCULATIONAHA.117.030458.
    PubMed     Text format     Abstract available


  44. YOUNG LH, Viscoli CM, Inzucchi SE, Kernan WN, et al
    Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1567-1568.
    PubMed     Text format    


  45. JIN-SHAN H, Xue-Bin L
    Letter by Jin-Shan and Xue-Bin Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1565-1566.
    PubMed     Text format    


  46. MUSSO G, Cassader M, Gambino R
    Letter by Musso et al Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".
    Circulation. 2017;136:1563-1564.
    PubMed     Text format    


  47. SMITH EE, Saver JL, Cox M, Liang L, et al
    Increase in Endovascular Therapy in Get With The Guidelines-Stroke After The Publication of Pivotal Trials.
    Circulation. 2017 Oct 5. pii: CIRCULATIONAHA.117.031097.
    PubMed     Text format     Abstract available


    September 2017
  48. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Text format     Abstract available


  49. FROEHLER MT, Saver JL, Zaidat OO, Jahan R, et al
    Interhospital Transfer Prior to Thrombectomy is Associated with Delayed Treatment and Worse Outcome in the STRATIS Registry.
    Circulation. 2017 Sep 24. pii: CIRCULATIONAHA.117.028920.
    PubMed     Text format     Abstract available


    August 2017
  50. HOPKINS LN, Holmes DR Jr
    Response by Hopkins and Holmes to Letter Regarding Article, "Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke".
    Circulation. 2017;136:781-782.
    PubMed     Text format    



  51. Letter by the Society of NeuroInterventional Surgery, the Cerebrovascular Section of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons, and the Society of Vascular and Interventional Neurology Regarding Articl
    Circulation. 2017;136:779-780.
    PubMed     Text format    


    July 2017
  52. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    PubMed     Text format     Abstract available


    June 2017
  53. BIVARD A, Muir K, Parsons M
    Response by Bivard et al to Letter Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1141-e1142.
    PubMed     Text format    


  54. ROOZENBEEK B, Dippel DWJ, Lingsma HF
    Letter by Roozenbeek et al Regarding Article, "Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials".
    Circulation. 2017;135:e1139-e1140.
    PubMed     Text format    


    March 2017
  55. HOPKINS LN, Holmes DR Jr
    Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke.
    Circulation. 2017;135:1188-1190.
    PubMed     Text format    


    February 2017
  56. CARNICELLI AP, De Caterina R, Halperin JL, Renda G, et al
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.
    PubMed     Text format     Abstract available


    January 2017
  57. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed     Text format    


  58. ALBERTS MJ
    Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.
    Circulation. 2017;135:140-142.
    PubMed     Text format    


    September 2016
  59. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: